Several radiolabeled compounds targeting survivin have been developed for tumor imaging, including radioiodinated 4,6-diaryl-3-cyano-2-pyridinone derivatives [67] and 3-phenethyl-2-indolinone derivatives [68]. This evidence concerns the gene BIRC5 and neoplasm.